Physician profile
Anne Kunkler
NPI 1679060297
$4,667.94
in general payments reported to CMS, 2019-2025
22 companies · $1,095 in 2025
The $1,095 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $24.90 · 2021: $145 · 2022: $1,098 · 2023: $936 · 2024: $1,154 · 2025: $1,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,356 · Consulting Fee: $500 · Entertainment: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,356.04 |
| Consulting Fee | $500.00 |
| Entertainment | $330.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $930.49 | 2021-2025 | Constellation, Clareon Panoptix Pro, Ngenuity |
| Dutch Ophthalmic, USA | $818.04 | 2022-2024 | Eva, Combined Machine, Tissueblue |
| Genentech USA, INC. | $379.27 | 2020-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $368.44 | 2023-2025 | Izervay |
| Optos, INC. | $330.06 | 2024-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Genentech, INC. | $280.97 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $198.49 | 2023-2025 | Eylea Hd, Eylea |
| Eyepoint US, INC. | $175.59 | 2022 | |
| Abbvie INC. | $153.29 | 2024-2025 | |
| Dompe US, INC. | $147.51 | 2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $121.87 | 2025 | Xdemvy |
| Coherus Oncology, INC. | $117.39 | 2022 | |
| Bausch & Lomb Americas INC. | $99.78 | 2022 | |
| Lkc Technologies, INC. | $90.09 | 2025 | |
| Alimera Sciences, INC. | $85.61 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $83.70 | 2019 | |
| Harrow Eye, LLC | $68.22 | 2025 | Triesence, Iheezo |
| Apellis Pharmaceuticals, INC. | $65.86 | 2025 | Syfovre |
| Mallinckrodt Hospital Products INC. | $63.20 | 2025 | Acthar |
| Carl Zeiss Meditec USA, INC. | $44.10 | 2025 | Cirrus Hd-Oct |
| Ani Pharmaceuticals, INC. | $25.07 | 2025 | Iluvien |
| Biotissue Holdings INC. | $20.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Kunkler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.